Ligand Activation of the Aryl Hydrocarbon Receptor Upregulates Epidermal Uridine Diphosphate Glucose Ceramide Glucosyltransferase and Glucosylceramides

Sutter, Carrie Hayes; Azim, Shafquat; Wang, Anyou; Bhuju, Jyoti; Simpson, Amelia S; Uberoi, Aayushi; Grice, Elizabeth A.; Sutter, Thomas R.

doi:10.1016/j.jid.2023.03.1662

Journal of Investigative Dermatology

2023

DOI: 10.1016/j.jid.2023.03.1662

|View full text |Cite

Ligand Activation of the Aryl Hydrocarbon Receptor Upregulates Epidermal Uridine Diphosphate Glucose Ceramide Glucosyltransferase and Glucosylceramides

Carrie Hayes Sutter¹,

Shafquat Azim²,

Anyou Wang³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

2024

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 7 publications

References 67 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Tapinarof validates the aryl hydrocarbon receptor as a therapeutic target: A clinical review

Silverberg,

Boguniewicz,

Quintana

et al. 2024

Journal of Allergy and Clinical Immunology

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Ligand Activation of the Aryl Hydrocarbon Receptor Upregulates Epidermal Uridine Diphosphate Glucose Ceramide Glucosyltransferase and Glucosylceramides

Cited by 7 publications

References 67 publications

Tapinarof validates the aryl hydrocarbon receptor as a therapeutic target: A clinical review

Tapinarof validates the aryl hydrocarbon receptor as a therapeutic target: A clinical review

Modulation of Aryl Hydrocarbon Receptor Can Be a Strategy to Improve Epidermal Barrier Function by Increasing Glucosylceramide Synthesis

Barrier Abnormalities in Type 1 Diabetes Mellitus: The Roles of Inflammation and Ceramide Metabolism

Contact Info

Product

Resources

About